Clinical Trial Update: Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomania or Mild Mania [Phase 3]

View source ↗

Summary

This clinical trial update indicates completion of a Phase 3 study evaluating divalproex extended-release as monotherapy for ambulatory bipolar spectrum disorde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• DEPAKOTE ER (DIVALPROEX SODIUM)

Snippet

Sponsor: Lindner Center of HOPE | Conditions: Bipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild Mania | Phase 3 | Status: COMPLETED